ConductScience.org, home

Paper110422

Diphosphonates.

Fleisch H and 1 other. Calcif Tissue Int, 1979. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Diphosphonates. Papers, record 110422. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/110422

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diphosphonates.
PubMed
Journal
Calcif Tissue Int
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
4.26
iCite
Revised in PubMed
2019-08-27
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fleisch HH
2Felix RR

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DiphosphonatesMajor topic
Animals
Bone and Bones
Dihydroxycholecalciferols
Homeostasis
Humans
Osteitis Deformans
Structure-Activity Relationship
Tooth
Vitamin D Deficiency

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
8845585Bisphosphonates and the treatment of bone disease in the elderly.Drugs Aging1996https://conductscience.org/library/papers/8845585PubMed
8494721Inhibition by a new bisphosphonate (YM175) of bone resorption induced by the MBT-2 tumour of mice.Br J Cancer1993https://conductscience.org/library/papers/8494721PubMed
7522963Comparative study of inhibitory effects by murine interferon gamma and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK).Cancer Immunol Immunother1994https://conductscience.org/library/papers/7522963PubMed
7516074Palliative medicine.Postgrad Med J1993https://conductscience.org/library/papers/7516074PubMed
6809282Focal mineralization defect during disodium etidronate treatment of calcinosis.Calcif Tissue Int1982https://conductscience.org/library/papers/6809282PubMed
6458287The effects of 1-hydroxyethane-1,1-diphosphonate and dichloromethanediphosphonate on collagen synthesis by rabbit articular chondrocytes and rat bone cells.Biochem J1981https://conductscience.org/library/papers/6458287PubMed
6282409Blood: bone disequilibrium. V. Effects of a diphosphonate (EHDP) on phosphate fluxes in rat calvaria.Calcif Tissue Int1982https://conductscience.org/library/papers/6282409PubMed
3297448Perspectives in the treatment of cancer metastasis.Clin Exp Metastasis1987https://conductscience.org/library/papers/3297448PubMed
3119600A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium.J Cancer Res Clin Oncol1987https://conductscience.org/library/papers/3119600PubMed
3094242Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas.Virchows Arch A Pathol Anat Histopathol1986https://conductscience.org/library/papers/3094242PubMed
1912831Treating bony metastases.BMJ1991https://conductscience.org/library/papers/1912831PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/110422

GET https://conductscience.org/api/papers/v1/110422/authors